What is a stock summary page? Click here for an overview.
Business Description
Soleno Therapeutics Inc
NAICS : 541713
SIC : 2834
ISIN : US8342032005
Compare
Compare
Traded in other countries / regions
SLNO.USA6XC.Germany Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2014-11-13Description
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.52 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 8.8 | |||||
| 3-Year EPS without NRI Growth Rate | 10.7 | |||||
| 3-Year FCF Growth Rate | 30.9 | |||||
| 3-Year Book Growth Rate | 17.1 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.35 | |||||
| 9-Day RSI | 46.16 | |||||
| 14-Day RSI | 51.21 | |||||
| 3-1 Month Momentum % | 0.58 | |||||
| 6-1 Month Momentum % | -13.83 | |||||
| 12-1 Month Momentum % | 11.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.68 | |||||
| Quick Ratio | 15.68 | |||||
| Cash Ratio | 15.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -104.8 | |||||
| Shareholder Yield % | -5.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -80.56 | |||||
| ROA % | -68.62 | |||||
| ROIC % | -556.37 | |||||
| 3-Year ROIIC % | -496.35 | |||||
| ROC (Joel Greenblatt) % | -12123.36 | |||||
| ROCE % | -72.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.79 | |||||
| Price-to-Tangible-Book | 12.13 | |||||
| EV-to-EBIT | -14.13 | |||||
| EV-to-Forward-EBIT | -17.67 | |||||
| EV-to-EBITDA | -14.29 | |||||
| EV-to-Forward-Revenue | 75.24 | |||||
| EV-to-FCF | -41.18 | |||||
| Price-to-Net-Current-Asset-Value | 13.89 | |||||
| Price-to-Net-Cash | 14.04 | |||||
| Earnings Yield (Greenblatt) % | -7.08 | |||||
| FCF Yield % | -2.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLNO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Soleno Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.26 | ||
| Beta | -3.38 | ||
| 3-Year Sharpe Ratio | 0.81 | ||
| 3-Year Sortino Ratio | 5.83 | ||
| Volatility % | 54.05 | ||
| 14-Day RSI | 51.21 | ||
| 14-Day ATR ($) | 5.130996 | ||
| 20-Day SMA ($) | 58.07 | ||
| 12-1 Month Momentum % | 11.09 | ||
| 52-Week Range ($) | 36.61 - 74 | ||
| Shares Outstanding (Mil) | 45.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Soleno Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Soleno Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Soleno Therapeutics Inc Frequently Asked Questions
What is Soleno Therapeutics Inc(SLNO)'s stock price today?
The current price of SLNO is $63.18. The 52 week high of SLNO is $74.00 and 52 week low is $36.61.
When is next earnings date of Soleno Therapeutics Inc(SLNO)?
The next earnings date of Soleno Therapeutics Inc(SLNO) is 2025-08-07 Est..
Does Soleno Therapeutics Inc(SLNO) pay dividends? If so, how much?
Soleno Therapeutics Inc(SLNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers